PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of wtpaEurope PMCEurope PMC Funders GroupSubmit a Manuscript
 
J Neurosci. Author manuscript; available in PMC 2010 December 16.
Published in final edited form as:
PMCID: PMC2912510
EMSID: UKMS31081

In vivo composition of NMDA receptor signalling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93

Abstract

Lipid rafts are dynamic membrane microdomains enriched in cholesterol and sphingolipids involved in the compartmentalization of signaling pathways, trafficking and sorting of proteins. At synapses, the glutamatergic NMDA receptor and its cytoplasmic scaffold protein PSD-95 move between postsynaptic density (PSD) and rafts following learning or ischemia. However it is not known if the signaling complexes formed by these proteins are different in rafts nor the molecular mechanisms that govern their localization. To examine these issues in vivo we used mice carrying genetically encoded tags for purification of protein complexes and specific mutations in NMDA receptors, PSD-95 and other postsynaptic scaffold proteins. Isolation of PSD-95 complexes from mice carrying tandem affinity purification tags showed differential composition in lipid rafts, postsynaptic density and detergent-soluble fractions. Raft PSD-95 complexes showed less CamKIIα and SynGAP and enrichment in Src and Arc/Arg3.1 compared with PSD complexes. Mice carrying knockouts of PSD-95 or PSD-93 show a key role for PSD-95 in localizing NR2A containing NMDA receptor complexes to rafts. Deletion of the NR2A carboxyl-terminus or the carboxyl-terminal valine residue of NR2B, which prevents all PDZ interactions, reduced the NR1 association with rafts. Interestingly, the deletion of the NR2B valine residue increased the total amount of lipid rafts. These data show critical roles for scaffold proteins and their interactions with NMDA receptor subunits in organizing the differential expression in rafts and postsynaptic densities of synaptic signaling complexes.

Keywords: Lipid rafts, NMDAR, PSD-95, complexes, postsynaptic density, signal compartmentalization

Introduction

Biological membranes are composed of different subdomains that compartmentalize the spatial distribution of receptors and membrane-proximal effectors. Lipid rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains. Lipid rafts enriched in saturated fatty acids are dispersed in the more fluid liquid-disordered phase of more unsaturated lipids (Pike, 2006). Signaling proteins with affinity for rafts become concentrated in these microdomains, thus facilitating formation of protein complexes and activation of specific signaling pathways (Simons et al., 1998).

Single-quantum dot imaging of glycophosphatidyl-inositol anchored green fluorescent protein in mammalian synapses found postsynaptic membranes had lipid-raft properties (Renner et al., 2009). Several studies showed rafts and PSDs share important signaling proteins including neurotransmitter receptors such as NMDA receptors (NMDAR), the scaffolding protein PSD-95 and downstream kinases (Becher et al., 2001; Suzuki et al., 2001; Ma et al., 2003; Guirland et al., 2004; Besshoh et al., 2005). Moreover, movement of NMDAR from lipid rafts to PSDs was reported following ischemia and this was correlated with increased tyrosine phosphorylation of NR2A and NR2B subunits in rafts (Besshoh et al., 2005). The shift of NMDAR and PSD-95 between PSD and rafts also occurs with spatial learning induced in the water maze (Delint-Ramirez et al., 2008). These data suggests the possibility that signaling complexes formed by NMDAR and PSD-95 may have different signaling functions in rafts.

PSD-95 is a palmitoylated protein of the membrane associated guanylate kinase family (MAGUK) (Melkonian et al., 1999; Zacharias et al., 2002) and promotes the association of others proteins with lipid rafts (Ma et al., 2003; Wong and Schlichter, 2004). The C-terminal ESDV motifs of NR2A and NR2B directly interact with the PDZ domains of MAGUKs (Kornau et al., 1995; Sheng, 2001) to form multiprotein complexes known as the NMDAR complex/MAGUK associated signalling complex (NRC/MASC) (Husi et al., 2000; Husi and Grant, 2001; Collins et al., 2006; Emes et al., 2008). Proteomic studies of NRC/MASC has identified scaffold proteins, kinases, phosphatases, GTPase-activating proteins and effectors which are key components of diverse signal transduction pathways (Husi et al., 2000; Husi and Grant, 2001; Collins et al., 2005; Collins et al., 2006; Coba et al., 2009). A powerful new method for isolating mouse protein complexes, where endogenous PSD-95 is genetically modified to encode a Tandem Affinity Purification (TAP) tag, shows 118 proteins comprising key electrophysiological machinery of the postsynaptic excitatory synapse (Fernandez et al., 2009). These genetically modified mice, known as PSD-95TAP mice, have broad application in the study of synapse complexes.

Here we use PSD-95TAP mice to study the composition of PSD-95 complexes in lipid rafts. Using mice carrying knockouts in MAGUK proteins, deletions of specific domains and point mutations of NMDAR subunits we identify the role of specific protein interactions promoting the association of signalling complexes with rafts.

Materials & Methods

Genetically modified mice

Animals were treated in accordance with UK Animal Scientific Procedures Act (1986) and NIH guidelines. All the experiments were performed using wild type and homozygous littermates matched animals.

PSD-95TAP mice: Knockin mice in which a Tandem Affinity Purification (TAP) tag was inserted into the endogenous locus of PSD-95 (Fernandez et al., 2009). The TAP tag consists of a poly-histidine affinity tag (HAT) and a triple FLAG tag (Terpe, 2003) separated by a unique TEV-protease cleavage site (Fernandez et al., 2009).

PSD-93−/− knockout mice do not express detectable levels of the protein PSD-93 (McGee et al., 2001).

PSD-95−/− knockout mice do not express detectable levels of the protein PSD-95 (Yao et al., 2004)

NR2AΔC/ΔC mice that express NR2A subunit lacking the intracellular C-terminal domain were constructed by deleting the C-terminal exon of the NR2A subunit gene (Sprengel et al., 1998).

NR2B ΔV/ΔV mice express the NR2B subunit carrying a deletion of the C-terminal Valine 1482. A detailed description of the generation of these mutant mice is in preparation (N. H. Komiyama, E. Kicsi, S. G. N. Grant, unpublished).

Antibodies

Mouse anti-NR1 (cat. 320500 Zymed, San Francisco, CA), rabbit anti-NR2A (cat. OPA1-04021, Affinity BioReagents-Thermo Fisher Scientific, Rockford, IL), rabbit anti-NR2A (cat. 07-632, Upstate-Millipore, Billerica, MA), rabbit anti-NR2A (n-terminal) (cat. AHP1880 ABD-Serotec, MorphoSys, Oxford) mouse anti-NR2B (cat. 610416/7, BD biosciences San Jose, California), mouse anti-PSD-95 (cat. MA1-045, Affinity BioReagents-Thermo Fisher Scientific, Rockford, IL), mouse anti-PSD-93 (cat. 75-057, NeuroMab, Davis, CA), mouse anti-PSD-93 (cat. 75-058 NeuroMab, Davis, CA), rabbit anti-SRC (cat. ab7950 Abcam Cambridge UK), mouse anti-actin (cat. ab3280, Abcam, Cambridge, UK) rabbit anti-Flotilli-1 (Cat. Sigma-Aldrich, St. Louis, MO), mouse anti-Arc (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-Syngap (cat. PA1-046 Affinity BioReagents-Thermo Fisher Scientific, Rockford, IL), rabbit anti- 1252 PY -NR2B (cat. ab18532, Abcam, Cambridge UK).

Isolation of lipid rafts

Lipid rafts were prepared from insoluble extract of homogenate tissue as described previously (Marta et al., 2003) with some modifications (Delint-Ramirez et al., 2008). Mouse cortex was homogenized in lysis buffer (0.5 ml of 150mM NaCl, 25mM Tris-HCl pH 7.5, containing 50 mM NaF, 10 mM NaP2O7, 1 mM Sodium orthovanadate, complete protease inhibitors cocktail (Roche, Mannheim, Germany) and 1% Triton X-100). Following homogenization (thirty strokes) with a Teflon glass homogenizer the sample was centrifuged 10 min at 1500 × g and protein concentration determined by Bradford assay. The supernatant (3 or 3.5mg of protein) was incubated for 30 min at 4°C and centrifuged 15 min at 16,000 × g at 4°C, to separate a Triton X-100 soluble extract and the insoluble pellet. The pellet was resuspended in 0.5 ml of lysis buffer and mixed with 2 M sucrose (1 ml), overlaid with 1 M (2 ml) and 0.2 M (1.5 ml) sucrose and centrifuged for 18 h at 200,000 × g (SW 50 Ti; Beckman) at 4°C. After centrifugation, five 1 ml fractions were collected at 4°C from the top (fraction 1) to the bottom of the gradient. The pellet was resuspended in 1ml of lysis buffer. Protein concentration was measured by Bradford assay. Equal volumes of each gradient fraction were measured for the lipid rafts markers GM1, cholesterol, Src and flotillin-1. The highest concentration of all these proteins was found in fraction 2 (Fig.1) as previously reported. The pellet is a high-density insoluble fraction that contains the major proportion of postsynaptic density proteins (PSD-93, PSD-95, GLUR1, NMDAR). The pellet did not show any detectable levels of lipids such as cholesterol or GM1 (Fig. 1), thus we considered this fraction contains the PSDs depleted of lipid rafts (Fig. 1). Therefore, fraction 2 is referred to as the lipid raft fraction and the pellet as PSD fraction.

Fig. 1
Composition of the PSD95-NMDAR complex in lipid rafts and PSD fractions

Isolation of PSD-95 complexes

Lipid rafts and PSD fractions were isolated from PSD-95TAP mice. Lipid rafts fraction (1ml) were diluted with 4ml of 150mM NaCl, 25mM Tris-HCl pH 7.5, containing complete protease inhibitors cocktail (Roche, Mannheim, Germany) and centrifuged for 35 min at 45,000 rpm. (SW 50 Ti; Beckman) at 4°C. The lipid rafts pellet and the PSD fraction were resuspended by sonication in 0.3 ml of lysis buffer plus 0.2% sodium deoxycholate. Both extracts were centrifuged for 15 min at 16,000 × g at 4°C and the supernatants were incubated with anti-FLAG antibody covalently coupled to Dynal beads (Invitrogen Ltd, Paisley UK). After 2 hours of mixing at 4°C, the beads were washed three times with 0.4 ml of lysis buffer and once with 0.4 ml of 150mM NaCl, 25mM Tris-HCl pH 7.5. The tagged protein was cleaved from the beads by addition of TEV protease as previously described (Fernandez et al., 2009).

Immunoblot analysis

Equal volumes of each fraction or 2 μg of protein from lipid rafts and PSD fractions, 120 μg from detergent-soluble extract and 20 μg from homogenized mice cortex were mixed with NuPAGE LDS Sample Buffer plus 5% β-mercapto-ethanol, boiled and separated in 4-12% LDS Bis-Tris Gels (NuPAGE, Invitrogen). Proteins were electrophoretically transferred to PVDF membrane at 40V overnight. The membrane was then blocked for 2 h at RT in TBS -T buffer (Tris 10mM, NaCl 0.9%, Tween 20 0.1%, ph 7.5) containing 5% BSA. Membranes were incubated with primary antibodies for 24 h at 4°C, washed (4 times/5 min) in TBS-T, and incubated for 1 h with HRP-conjugated secondary antibody. Negative controls were prepared by omission of primary antibodies. Proteins were detected by ECL (Immobilon™ Wester, Millipore, Billerica, USA) and visualized by Kodak Image Station. Levels of immunoreactivity were quantified densitometrically with the ImageJ 1.31V software (Wayne Rasband, National Institutes of Health, USA).

Determination of lipid amount

To determine the level of monosialoganglioside (GM1), 1 μl of each density gradient fraction were dot blotted onto nitrocellulose, and blocked as described above. After incubation with HRP-conjugated cholera toxin B (1/10.000) (Sigma, Saint Louis Missouri, USA), the dots were revealed by chemiluminescence as above. Cholesterol concentration was determined colorimetrically by enzymatic method using Total Cholesterol Test kit (Wako Pure Chemical Ind., Ltd Osaka, Japan). Equal volumes of the fractions of the gradients were analyzed.

Statistical analysis

Statistical differences between samples were evaluated using the unpaired Student's t-test. We use a minimum of 5 litter matched pairs of animals, except detergent-soluble extract (4 litter matched pair of animals). All results are expressed as the mean ± SEM.

Results

NMDAR-PSD-95 complexes isolated from lipid rafts

Figure 1A shows fractionation of mouse cortex extracts into lipid rafts (fraction 2), PSDs (pellet) and other fractions (see methods) from wild type and PSD-95TAP mice. Equal amounts of protein from the lipid rafts and PSD fractions were then subject to affinity purification of PSD-95-NMDAR complexes followed by immunoblotting for NMDA receptor subunits, MAGUKs and other associated proteins (Fig. 1B). No proteins were detected in wild-type mice revealing the specificity of the TAP method (Fig. 1B).

Differential composition of PSD-95 complexes was observed between rafts and PSD (Fig. 1B). PSD-95 complexes isolated from lipid rafts had similar proportions of NR1 and NR2A subunits compared to those isolated from the PSD fraction (p > 0.05). However, several proteins were reduced in lipid rafts when compared to PSDs: NR2B (p < 0.01), SynGAP (p < 0.01) and CamKII (p < 0.01). In contrast to the reduction in these three proteins, very significant increases in the proportions of Arc (p < 0.01) and Src (p < 0.01) were observed in rafts. Since Src is known to phosphorylate NR2B on Y1252, we examined the phosphorylation of this site and found a higher phosphorylation of NR2B pY1252 in the lipid raft fraction, indicating the functional significance of the differential composition of the PSD-95 complexes in rafts. In addition to NR1 and NR2A we did not find significant differences in PSD-93 (p > 0.05) and SAP-102 (p = 0.08) levels amongst both fractions (Fig. 1B).

We next examined the detergent-soluble extract, which does not include rafts or PSD (see methods) to ask if this fraction also showed differential composition of PSD-95TAP complexes. As shown in Figure 1C, the soluble extract used for the affinity purification contains NR1, NR2B, PSD-95, Arc/Arg3.1 and CamKIIα, however these proteins were not assembled into complexes with PSD-95 (the soluble extract contains a total protein concentration about 60 times higher than the raft and PSD fractions) (Fig. 1D). Together these data show that complexes formed by PSD-95, NMDA receptor and their associated signaling proteins have differential composition in rafts, PSD and soluble fractions.

Differential roles for PSD-95 and PSD-93 in NMDAR association with lipid rafts

To test if MAGUK proteins influence the association of NMDA receptors (NMDAR) with rafts, we examined the distribution of NMDAR subunits in rafts, PSD and detergent-soluble fractions from mice lacking PSD-95 or PSD-93. We first examined PSD-95 knockout mice (PSD-95−/−) and confirmed that the total amount of cortical rafts was similar in wt and PSD-95−/− mice, as reflected by the unchanged levels of lipid rafts markers (GM1 and flotillin)(Fig. 2A). Then, we analyzed equal protein amounts of lipid rafts and PSDs by western blot for NMDAR subunits, MAGUKs (PSD-95 and PSD-93) and flotillin-1 or actin. Surprisingly, NR1 and NR2A concentrations in lipid rafts were higher in PSD-95−/− mice (Fig. 2A), while NR2B remained constant. Importantly, none of these molecules changed in their PSD concentration (Fig. 2B). The antibody used against PSD-95 detected a high molecular weight band (Fig. 2A) that disappeared in PSD-93−/− (Fig. 3A) indicating that the antibody also recognized PSD-93. Using this antibody we have seen that PSD-93 is also increased in the lipid fraction of PSD-95−/− animals while unchanged in the PSD.

Fig. 2
Analysis of PSD-95−/− knockout mice
Fig. 3
Analysis of PSD-93−/− knockout mice

We also analyzed the concentration of NMDAR subunits and PSD-93 in the detergent-soluble extract. The concentration of NR1, NR2A and PSD-93 decreased in this fraction, correlating with their increase in lipid rafts (Fig. 2D). In addition, the expression of NMDAR subunits in crude homogenate did not differ between PSD-95 −/− and wt mice (Fig. 2C). These data indicate that PSD-95 is required to modulate the levels of NR1, NR2A in rafts and soluble fractions.

Since the amino acid sequence of PSD-95 and PSD-93 reveals 71% identity, and the same domain organization including the palmitoylation motif (El-Husseini et al., 2000; Dakoji et al., 2003; Fitzjohn et al., 2006) the increase of NMDAR associated to lipid rafts in PSD-95−/− mice may be due to the increase of PSD-93 in this fraction. Therefore, we examined the distribution of the NMDA receptor subunits and other proteins in PSD-93−/− knockout mice. The only observed change was an increase in PSD-95 in the PSD fraction (Fig. 3B). This comparison shows that MAGUKs play a role in organising NMDA receptors in rafts, with PSD-95 playing a more important role than PSD-93.

Association of NMDAR with lipid rafts in mice with an NR2A C-terminal deletion

Results from the MAGUK mutant mice suggest the physical interaction between NR2 subunits and MAGUKs regulates the localization of NMDA receptor to rafts. Since this interaction is mediated by the cytoplasmic tail of NR2 subunits, we examined the distribution of NR1, NR2B and PSD-95 in lipid rafts, PSD and detergent-soluble fractions in mice lacking the cytoplasmic tail of NR2A protein (NR2AΔC/ΔC) (Sprengel et al., 1998) (Fig.4). Interestingly, we found a ~35% (p < 0.01) reduction of NR1 in the crude homogenate, reflecting an overall reduction in this protein (Fig.4C). This decrease in NR1 was greater in lipid rafts (~70%, p < 0.01) (Fig. 4A) than in PSD (~20%, p < 0.05) (Fig.4B). while remained unchanged in the soluble fraction. (Fig. 4D). Using an antibody that recognizes the amino-terminal domain of NR2A, we found in NR2AΔC/ΔC mice that the amount of NR2A was decreased ~70% in both the lipid rafts and the PSD fraction (p < 0.01), whereas it was increased more than 3 times in the soluble fraction. The total expression of the NR2A decreased ~ 50%. No changes were observed for NR2B in any of the fractions. We also observed that PSD-95 was reduced by ~35% (p < 0.01) in rafts (Fig. 4A). These data support the conclusion that the carboxyl intracellular domain of NR2A modulates the total level of NMDAR having its most significant effect in lipid rafts.

Fig. 4
Analysis of mice carrying a C-terminal truncation of NR2A subunits (NR2AΔC/ΔC)

NMDAR in lipid rafts from mice lacking the PDZ binding motif of NR2B

Since absence of the NR2A carboxyl intracellular domain decreased the amount of NMDAR in rafts we tested if lack of the NR2B PDZ binding motif would have an effect on NMDAR raft partitioning using NR2BΔV/ΔV mice. During the course of routine control experiments we measured total protein, GM1, cholesterol and flotillin-1 in the different fractions (Fig. 1A) and we unexpectedly found a change in raft composition in the NR2B ΔV/ΔV mice. The concentration of total protein and raft markers were increased by ~35% in the lipid raft fraction from NR2BΔV/ΔV animals compared to controls. No changes were observed in total protein in the PSD fraction (Fig. 5A). To confirm that this increase was specific to rafts, we measured GM1, flotillin-1 and cholesterol in the detergent-soluble and insoluble extracts: the increases were only present in the insoluble extract (lipid raft and PSD) (Fig. 5A). These increases in raft markers are consistent with an increase in the synthesis or stabilization of the lipid rafts components (Fig. 5D).

Fig. 5
Analysis of carrying a punctual deletion of the Valine 1482 of NR2B subunits (NR2B ΔV/ΔV)

This increase of rafts in NR2BΔV/ΔV mice was also associated with changes in the proportions of NMDAR subunits and MAGUK proteins. The relative amounts of NR1 and NR2B in rafts was decreased by ~40% (P<0.01) whereas NR2A, PSD-95 and actin were unchanged in NR2BΔV/ΔV mice (Fig. 5B). To clarify the net effect of the changes in raft amounts and the concentrations of the particular proteins we examined the total amounts of the proteins (per volume) and found NR1 and NR2B in raft fraction in NR2BΔV/ΔV mice was similar to levels in wild type extracts, while PSD-95 was increased (data not shown).

Unlike the rafts, the total amount of PSD proteins did not change in NR2BΔV/ΔV mice. Nevertheless, the mutation had a clear effect on NMDA receptor expression, since NR1 and NR2B concentration decreased by ~20% and ~25% respectively (p < 0.05). Conversely, the amount of NR2A was increased by ~45% in the PSD. This suggests a compensatory increase in NR2A occurred in the PSD. We also examined the detergent-soluble extract, where decreased levels of PSD95 and NR2A were observed and NR1 levels did not change (Fig. 5E). Moreover it should be noted that PSD-95 and actin was unchanged in PSDs and total homogenate indicating that the loss of the single residue from NR2B did not influence these scaffold and structural proteins in these fractions. Together these data indicate that the terminal valine residue of NR2B is required for the normal expression of synaptic signaling proteins in different synaptic compartments.

Discussion

Lipid rafts at excitatory synapses

Using genetically modified mice carrying a tandem affinity purification tag inserted into PSD-95 we demonstrate that neurotransmitter receptor signaling complexes have different composition and phosphorylation in PSD and rafts. While rafts have been described in a wide range of cells, we have focused on glutamatergic synapses where the complexes formed with PSD-95 are highly enriched in the postsynaptic terminal allowing us to separate excitatory synaptic rafts from those in other cells and compartments. Amongst the known important raft proteins at excitatory synapses are glutamate receptors: AMPA (Sprengel et al., 1998; Suzuki et al., 2001), NMDA (Besshoh et al., 2005; Delint-Ramirez et al., 2008; Wheeler et al., 2009) and metabotropic receptors (mGLUR1/5) (Francesconi et al., 2009); scaffold proteins such as PSD-95 (Wong and Schlichter, 2004; Suzuki et al., 2008) and GRIP (glutamate receptor-interacting protein)(Bruckner et al., 1999; Hering et al., 2003). Moreover, a number of raft markers have been localized to the postsynaptic terminal: flotillin-1 (Collins et al., 2006) that was also reported to interact with NMDA receptors (Swanwick et al., 2009); caveolin-1 found by electron microscopy (Petralia et al., 2003) and interacts with mGLUR receptors (Francesconi et al., 2009) and NMDARs were colocalised by confocal microscopy with the raft marker ganglioside GM1 (Frank et al., 2004). These data are all consistent with a model in which lipid rafts constitute an integral structural component of the postsynaptic apparatus and supports the suggestion that they are involved in the regulation of postsynaptic structure and function.

The ultrastructural organization of rafts within the postsynaptic terminal and their physical relationship with the PSD remains unclear. Evidence that the postsynaptic membrane has lipid-raft regions that limit the diffusion of molecules was observed using new microscopy methods and cholesterol depletion, which increased the mobility in the synaptic membrane of slowly diffusing molecules (Renner et al., 2009). This is also consistent with data showing that lipid rafts have a different viscosity and reduce the lateral mobility of their associated proteins (Lenne et al., 2006; Marguet et al., 2006). However, neither the percentage of the synaptic membrane, NMDARs or PSD-95 in lipid rafts been clearly determined. Previous studies have reported between 20% and 100% of PSD-95 in lipid rafts (Suzuki et al., 2001; Hering et al., 2003; Ma et al., 2003; Besshoh et al., 2005), however, the reasons for this variation are not known but may be related to different conditions of detergent extraction since differences in the ratio of detergent to protein is important for the extraction of the lipid raft proteins: a high ratio may disrupt weak interactions of proteins with raft domains (Lingwood and Simons, 2007), while a small ratio results in contamination of lipid rafts fractions with non-raft membrane (Pike, 2006). In the present study, the lipid raft fraction is heterogeneous, containing rafts from the synaptic region itself, as well as rafts from extrasynaptic membranes, the soma and the axons. The lipid rafts from inhibitory synapses will also be included particularly since inhibitory synapses present clearer lipid-raft properties (Renner et al., 2009). In our study we observed approximately 40% of the NMDAR associated with lipid rafts, 50% to the PSD and 10% in the soluble fraction and moreover, by focusing on PSD-95 complexes, which are highly enriched in the postsynaptic terminal of excitatory synapses in the TAP tag mice (Fernandez et al., 2009), we could examine the organization of their signaling complexes, which until now have not been characterized.

Differential organization of signaling pathways and complexes in rafts

Using mice expressing TAP tagged PSD-95, we compared the composition of the NMDAR-PSD-95 complexes isolated from lipid rafts with those from PSD and soluble fractions. We found that NMDAR-PSD-95 complexes in lipid rafts interact with different signaling proteins than the complexes isolated from the PSD and soluble fractions. The amount of Src and Arc/Arg3.1 was almost 3 fold higher in the raft PSD-95 complexes. Conversely, the amount of SynGAP and CaMKIIα in PSD-95 complexes was ≈25% and 50% less in rafts than PSDs.

All the differentially associated proteins are known to be important in synaptic plasticity (Malenka et al., 1989; O'Dell et al., 1991; Grant et al., 1992; Komiyama et al., 2002). Moreover, the pattern of differences in particular proteins between rafts and PSDs was clearly relevant to known functional interactions of these proteins. For example, CamKIIα and SynGAP, which were reduced in rafts, form part of a signaling pathway where Ca2+ entering via the NMDAR dissociates CaMKII from the complex, which drives the dephosphorylation of SynGAP inhibiting its GTPase activity (Krapivinsky et al., 2004). Src was enriched in rafts as was the enhanced tyrosine phosphorylation of NR2B, which is a known Src phosphorylation site (Besshoh et al., 2005) and important for synaptic physiology and behavior(Rosenblum et al., 1997; Ali and Salter, 2001; Zinebi et al., 2003; Barki-Harrington et al., 2009). This suggests the NMDAR-PSD-95 complexes in rafts support the Src-NR2B pathway and the complexes in PSDs support a CamKIIα-SynGAP pathway. Thus, increase in the association of the NMDAR with lipid rafts could promote the SRC signalling pathway after NMDAR activation, while decrease of the NMDAR affinity for rafts could promote the CamKII-SynGAP pathway activation.

CamKII is known to be associated with lipid rafts and ionomycin stimulation, which increases intracellular calcium, promotes CamKII clustering with lipid rafts (Du et al., 2006; Suzuki et al., 2008). The CamKII clusters stabilized (became resistant to treatment with methyl-β-cyclodextrin) the association of PSD-95 with lipid rafts. The ionomycin stimulation did not recruit PSD-95 to rafts suggesting that different proteins in the raft complexes can be differentially regulated in their recruitment to raft complexes. Both CamKII and PSD-95 interact with NMDA receptor NR2 subunits C-terminal domains (Parkin et al., 1990), which we found to be important in organization of raft proteins.

Similar to Src, we found Arc/Arg3.1 was mainly coupled to the NMDAR-PSD-95 complexes in rafts. Arc/Arg3.1 is an immediate-early gene whose mRNA is rapidly transcribed and targeted to dendrites of neurons, where it has been implicated in AMPA receptor endocytosis (Guzowski, 2002; Chowdhury et al., 2006; Plath et al., 2006; Shepherd et al., 2006). The enrichment of Arc/Arg3.1 in raft PSD-95 complexes suggests that Arc/Arg3.1 targeting to NMDA receptor complexes may preferentially localise to the PSD-95 complexes within rafts. Studies showing changes in NMDA receptor and PSD-95 in rafts following learning and plasticity (Besshoh et al., 2005; Delint-Ramirez et al., 2008) suggest these behaviors result in dynamic changes in the composition of the complexes.

Further evidence of differential composition of PSD-95 complexes in other cellular compartments was observed when examining the proteins associated with TAP tagged PSD-95 isolated from the detergent-soluble extract. There was a marked absence of the PSD-95 associated proteins, compared to rafts and PSDs, consistent with this complex being of extrasynaptic origin and perhaps representing PSD-95 in transit to the synapse where it assembles with its signalling partners.

The association of the proteins with lipid rafts is a very dynamic process (Pike, 2006) and future studies using fluorescent-tagged synaptic proteins may allow the trafficking of proteins between complexes and compartments to be studied. Very recently, advances in experimental techniques have allowed for the first time, non-invasive in vivo imaging of single diffusing lipid molecules and proteins with unprecedented spatial resolution (Kenworthy, 2007; Nunez-Jaramillo et al., 2008; de Almeida et al., 2009; Loura et al., 2009b; Loura et al., 2009a). These techniques show that lipid rafts are nanoscale (≈20nm areas) assemblies, highly dynamic, fluctuating on a sub-second timescale (pre-existing raft domains). These nanodomains can be stabilized by proteins that coalesce, forming platforms that function in membrane signaling and trafficking. When clustered, lipid raft components are thought to be laterally stabilized according to their underlying affinity for pre-existing raft domains (Lingwood and Simons, 2007; Kaiser et al., 2009). Our results suggest that in the synaptic membrane, the affinity of some proteins for lipid rafts allow their interaction with other proteins with affinity for this domain, which determines the formation of different protein complexes.

Roles for NR2 cytoplasmic domains and MAGUK proteins in raft complexes

Synaptic NMDAR subunit numbers and composition are dynamically remodelled during development and in response to neuronal activity and sensory experience. Several studies show this remodelling occurs by subunit insertion into the synaptic membrane, endocytosis or lateral mobility between the synaptic and extrasynaptic membrane (Zukin and Bennett, 1995; Wenthold et al., 2003). Less is known about the sorting of NMDA receptors and their scaffold and signalling proteins into lipid rafts and non raft membrane. In addition to finding evidence of differential distribution of these proteins, we also found that MAGUK proteins and NR2 cytoplasmic interaction domains were essential for regulating this distribution in vivo. Lack of PSD-95 increased the NR2A subunit in rafts and decreased it in the detergent-soluble extract without any significant effect on NR2B. It should be noted that PSD-93 was also increased in the rafts of PSD-95−/− mutant mice suggesting PSD-95 normally restrains NR2A/PSD-93 complexes from entering into rafts. In PSD-93 mutant mice, there was no detectable redistribution of NR2A, NR2B or PSD-95 suggesting that PSD-95 is a more important regulator of raft organisation, possibly because PSD95 is expressed about eight times as much as PSD-93 isoforms (Noritake et al., 2009). Additionally, our results suggest the MAGUK family plays a more important role on NR2A rather than NR2B since the knockout of PSD-95 affected the association of NR2A but not NR2B, and the deletion of the NR2A C-terminal tail decreased the association of NMDAR with lipid rafts by a greater amount than the mutation of the NR2B PDZ binding domain.

Direct evidence that NR2 cytoplasmic domains are involved in receptor and MAGUK distribution was found using mice lacking the cytoplasmic tail of the NR2A subunit. In these animals NR1 was reduced by 70% in rafts and 30% in PSDs. This did not affect synaptic NMDA receptor currents in CA3-CA1 synapses in these mutants (T.J. O'Dell personal communication). The simplest explanation is that NR2 C-terminal tail interactions with MAGUK proteins are involved in the NMDAR distribution, since mice carrying the point mutation in the PDZ binding domain of NR2B (NR2BΔV/ΔV) showed a reduction in the amount of NR2B in rafts. However we noticed that in the NR2AΔC/ΔC the amount of PSD-95 in rafts was also reduced. A potential mechanism that explains an NMDAR dependent mechanism for raft recruitment of PSD-95 is that signal transduction from NMDAR drives palmitoylation of PSD-95 (Noritake et al., 2009) and this palmitoylation is sufficient to target it to rafts (Shenoy-Scaria et al., 1994). It is possible that there is a cooperative role between palmitoylation regulated trafficking and protein-protein associations between NR2 subunits and MAGUKs. Further evidence for this concept is seen in data showing CaMKII regulates the recruitment of proteins to lipid rafts (Suzuki et al., 2008). Recently it was reported that the cytoplasmic tail of NR2A and NR2B have two distinct clusters of palmitoylation (Hayashi et al., 2009). The palmitoylation within the first cluster is on a membrane proximal region and involved in the association of the NMDAR-PSD-95 complex with lipid rafts and allows tyrosine phosphorylation of the NR2B subunit (pY 1472 and 1252) by Src family protein tyrosine kineses. This is consistent with our observation of this phosphorylation occurring mainly in rafts.

A surprising result from our study was that the absence of the terminal valine from the NR2B subunit changed the amount and composition of rafts. There was an approximately 30% increase in lipid rafts markers (GM1, cholesterol, and flotillin-1) and total protein. This increase of lipid raft markers was specifically in rafts since we did not detect changes in the detergent-soluble fraction. At the same time, this mutation decreased the concentration of NR1/NR2B in rafts and PSD by approximately 30%, which is in agreement with unpublished data showing a 30% reduction in the synaptic NMDA receptor currents (T.J. O'Dell, personal communication). The increase of lipid rafts could be a regulatory response mechanism to recuperate the amount of NMDAR and recover the glutamatergic signaling. This regulatory response may involve changes in synthesis of rafts and a candidate mechanism may involve the PI3K-AKT-SREBP pathway, known to regulate synthesis of cholesterol and fatty acids pathways (Porstmann et al., 2005; Shacka et al., 2006; Boonsong et al., 2007; Fuhrman et al., 2007; Smith et al., 2008) and also coupled to NMDA receptor and PSD-95 function (Opazo et al., 2003; Sanchez-Perez and Felipo, 2006; Sanchez-Perez et al., 2006; Yoshii and Constantine-Paton, 2007; Abbott et al., 2008) (McClean paper on PSD-95 SH3 in press).

Our study shows for the first time that signaling complexes between NMDA receptor and MAGUK proteins are differentially organized in rafts and other fractions and shows important roles for the interactions between these proteins. This report also illustrates how in vivo studies utilizing mice carrying genetically modified TAP tagged synaptic proteins and mutations can be combined to identify novel synaptic signaling mechanisms.

Acknowledgements

This work was supported by scholarship from CONACyT (México) and Coordinación de la Investigación Científica, UNAM to I. Delint-Ramirez. AB supported by EMBO and the European Commission. EF, EK, NHK, SGNG supported by the Wellcome Trust. PSD-93 mice provided by D. Bredt; NR2AΔC/ΔC provided by P. Seeburg and R. Sprengel. D. Fricker, K. Elsegood for genotyping and colony management.

References

  • Abbott JJ, Howlett DR, Francis PT, Williams RJ. Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. Neurobiol Aging. 2008;29:992–1001. [PubMed]
  • Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol. 2001;11:336–342. [PubMed]
  • Barki-Harrington L, Elkobi A, Tzabary T, Rosenblum K. Tyrosine phosphorylation of the 2B subunit of the NMDA receptor is necessary for taste memory formation. J Neurosci. 2009;29:9219–9226. [PubMed]
  • Becher A, White JH, McIlhinney RA. The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J Neurochem. 2001;79:787–795. [PubMed]
  • Besshoh S, Bawa D, Teves L, Wallace MC, Gurd JW. Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem. 2005;93:186–194. [PubMed]
  • Boonsong T, Norton L, Chokkalingam K, Jewell K, Macdonald I, Bennett A, Tsintzas K. Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways. Biochem Soc Trans. 2007;35:1310–1311. [PubMed]
  • Bruckner K, Pablo Labrador J, Scheiffele P, Herb A, Seeburg PH, Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron. 1999;22:511–524. [PubMed]
  • Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, Kuhl D, Huganir RL, Worley PF. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron. 2006;52:445–459. [PMC free article] [PubMed]
  • Coba MP, Pocklington AJ, Collins MO, Kopanitsa MV, Uren RT, Swamy S, Croning MD, Choudhary JS, Grant SG. Neurotransmitters drive combinatorial multistate postsynaptic density networks. Sci Signal. 2009;2:ra19. [PMC free article] [PubMed]
  • Collins MO, Yu L, Coba MP, Husi H, Campuzano I, Blackstock WP, Choudhary JS, Grant SG. Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol Chem. 2005;280:5972–5982. [PubMed]
  • Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, Blackstock WP, Choudhary JS, Grant SG. Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem. 2006;97(Suppl 1):16–23. [PubMed]
  • Dakoji S, Tomita S, Karimzadegan S, Nicoll RA, Bredt DS. Interaction of transmembrane AMPA receptor regulatory proteins with multiple membrane associated guanylate kinases. Neuropharmacology. 2003;45:849–856. [PubMed]
  • de Almeida RF, Loura LM, Prieto M. Membrane lipid domains and rafts: current applications of fluorescence lifetime spectroscopy and imaging. Chem Phys Lipids. 2009;157:61–77. [PubMed]
  • Delint-Ramirez I, Salcedo-Tello P, Bermudez-Rattoni F. Spatial memory formation induces recruitment of NMDA receptor and PSD-95 to synaptic lipid rafts. J Neurochem. 2008;106:1658–1668. [PubMed]
  • Du F, Saitoh F, Tian QB, Miyazawa S, Endo S, Suzuki T. Mechanisms for association of Ca2+/calmodulin-dependent protein kinase II with lipid rafts. Biochem Biophys Res Commun. 2006;347:814–820. [PubMed]
  • El-Husseini AE, Topinka JR, Lehrer-Graiwer JE, Firestein BL, Craven SE, Aoki C, Bredt DS. Ion channel clustering by membrane-associated guanylate kinases. Differential regulation by N-terminal lipid and metal binding motifs. J Biol Chem. 2000;275:23904–23910. [PubMed]
  • Emes RD, Pocklington AJ, Anderson CN, Bayes A, Collins MO, Vickers CA, Croning MD, Malik BR, Choudhary JS, Armstrong JD, Grant SG. Evolutionary expansion and anatomical specialization of synapse proteome complexity. Nat Neurosci. 2008;11:799–806. [PMC free article] [PubMed]
  • Fernandez E, Collins MO, Uren RT, Kopanitsa MV, Komiyama NH, Croning MD, Zografos L, Armstrong JD, Choudhary JS, Grant SG. Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol Syst Biol. 2009;5:269. [PMC free article] [PubMed]
  • Fitzjohn SM, Doherty AJ, Collingridge GL. Promiscuous interactions between AMPA-Rs and MAGUKs. Neuron. 2006;52:222–224. [PubMed]
  • Francesconi A, Kumari R, Zukin RS. Regulation of group I metabotropic glutamate receptor trafficking and signaling by the caveolar/lipid raft pathway. J Neurosci. 2009;29:3590–3602. [PMC free article] [PubMed]
  • Frank C, Giammarioli AM, Pepponi R, Fiorentini C, Rufini S. Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS letters. 2004;566:25–29. [PubMed]
  • Fuhrman B, Nitzan O, Karry R, Volkova N, Dumler I, Aviram M. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis. 2007;195:e108–116. [PubMed]
  • Grant SG, O'Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. Impaired long-term potentiation, spatial learning, and hippocampal development in fyn mutant mice. Science. 1992;258:1903–1910. [PubMed]
  • Guirland C, Suzuki S, Kojima M, Lu B, Zheng JQ. Lipid rafts mediate chemotropic guidance of nerve growth cones. Neuron. 2004;42:51–62. [PubMed]
  • Guzowski JF. Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches. Hippocampus. 2002;12:86–104. [PubMed]
  • Hayashi T, Thomas GM, Huganir RL. Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking. Neuron. 2009;64:213–226. [PMC free article] [PubMed]
  • Hering H, Lin CC, Sheng M. Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci. 2003;23:3262–3271. [PubMed]
  • Husi H, Grant SG. Isolation of 2000-kDa complexes of N-methyl-D-aspartate receptor and postsynaptic density 95 from mouse brain. J Neurochem. 2001;77:281–291. [PubMed]
  • Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci. 2000;3:661–669. [PubMed]
  • Kaiser HJ, Lingwood D, Levental I, Sampaio JL, Kalvodova L, Rajendran L, Simons K. Order of lipid phases in model and plasma membranes. Proc Natl Acad Sci U S A. 2009;106:16645–16650. [PubMed]
  • Kenworthy AK. Fluorescence recovery after photobleaching studies of lipid rafts. Methods Mol Biol. 2007;398:179–192. [PubMed]
  • Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, Monti J, Strathdee DJ, O'Carroll CM, Martin SJ, Morris RG, O'Dell TJ, Grant SG. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J Neurosci. 2002;22:9721–9732. [PubMed]
  • Kornau HC, Schenker LT, Kennedy MB, Seeburg PH. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science. 1995;269:1737–1740. [PubMed]
  • Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham DE. SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron. 2004;43:563–574. [PubMed]
  • Lenne PF, Wawrezinieck L, Conchonaud F, Wurtz O, Boned A, Guo XJ, Rigneault H, He HT, Marguet D. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J. 2006;25:3245–3256. [PubMed]
  • Lingwood D, Simons K. Detergent resistance as a tool in membrane research. Nat Protoc. 2007;2:2159–2165. [PubMed]
  • Loura LM, Fernandes F, Prieto M. Membrane microheterogeneity: Forster resonance energy transfer characterization of lateral membrane domains. Eur Biophys J. 2009a [PubMed]
  • Loura LM, de Almeida RF, Silva LC, Prieto M. FRET analysis of domain formation and properties in complex membrane systems. Biochim Biophys Acta. 2009b;1788:209–224. [PubMed]
  • Ma L, Huang YZ, Pitcher GM, Valtschanoff JG, Ma YH, Feng LY, Lu B, Xiong WC, Salter MW, Weinberg RJ, Mei L. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J Neurosci. 2003;23:3164–3175. [PubMed]
  • Malenka RC, Kauer JA, Perkel DJ, Mauk MD, Kelly PT, Nicoll RA, Waxham MN. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature. 1989;340:554–557. [PubMed]
  • Marguet D, Lenne PF, Rigneault H, He HT. Dynamics in the plasma membrane: how to combine fluidity and order. EMBO J. 2006;25:3446–3457. [PubMed]
  • Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci. 2003;23:5461–5471. [PubMed]
  • McGee AW, Topinka JR, Hashimoto K, Petralia RS, Kakizawa S, Kauer FW, Aguilera-Moreno A, Wenthold RJ, Kano M, Bredt DS. PSD-93 knock-out mice reveal that neuronal MAGUKs are not required for development or function of parallel fiber synapses in cerebellum. J Neurosci. 2001;21:3085–3091. [PubMed]
  • Melkonian KA, Ostermeyer AG, Chen JZ, Roth MG, Brown DA. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J Biol Chem. 1999;274:3910–3917. [PubMed]
  • Noritake J, Fukata Y, Iwanaga T, Hosomi N, Tsutsumi R, Matsuda N, Tani H, Iwanari H, Mochizuki Y, Kodama T, Matsuura Y, Bredt DS, Hamakubo T, Fukata M. Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95. J Cell Biol. 2009;186:147–160. [PMC free article] [PubMed]
  • Nunez-Jaramillo L, Jimenez B, Ramirez-Munguia N, Delint-Ramirez I, Luna-Illades C, Tapia R, Bermudez-Rattoni F. Taste novelty induces intracellular redistribution of NR2A and NR2B subunits of NMDA receptor in the insular cortex. Brain Res. 2008;1215:116–122. [PubMed]
  • O'Dell TJ, Kandel ER, Grant SG. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature. 1991;353:558–560. [PubMed]
  • Opazo P, Watabe AM, Grant SG, O'Dell TJ. Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J Neurosci. 2003;23:3679–3688. [PubMed]
  • Parkin AJ, Reid TK, Russo R. Mem Cog. 1990;18:507–514. [PubMed]
  • Petralia RS, Wang YX, Wenthold RJ. Internalization at glutamatergic synapses during development. Eur J Neurosci. 2003;18:3207–3217. [PubMed]
  • Pike LJ. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res. 2006;47:1597–1598. [PubMed]
  • Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, Mao X, Engelsberg A, Mahlke C, Welzl H, Kobalz U, Stawrakakis A, Fernandez E, Waltereit R, Bick-Sander A, Therstappen E, Cooke SF, Blanquet V, Wurst W, Salmen B, Bosl MR, Lipp HP, Grant SG, Bliss TV, Wolfer DP, Kuhl D. Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron. 2006;52:437–444. [PubMed]
  • Porstmann T, Griffiths B, Chung Y-L, Delpuech O, Griffiths JR, Downward J, Schulze A. PKB//Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. 2005;24:6465–6481. [PubMed]
  • Renner M, Choquet D, Triller A. Control of the postsynaptic membrane viscosity. J Neurosci. 2009;29:2926–2937. [PubMed]
  • Rosenblum K, Berman DE, Hazvi S, Lamprecht R, Dudai Y. NMDA receptor and the tyrosine phosphorylation of its 2B subunit in taste learning in the rat insular cortex. J Neurosci. 1997;17:5129–5135. [PubMed]
  • Sanchez-Perez AM, Felipo V. Chronic exposure to ammonia alters basal and NMDA-induced phosphorylation of NMDA receptor-subunit NR1. Neuroscience. 2006;140:1239–1244. [PubMed]
  • Sanchez-Perez AM, Llansola M, Felipo V. Modulation of NMDA receptors by AKT kinase. Neurochem Int. 2006;49:351–358. [PubMed]
  • Shacka JJ, Sahawneh MA, Gonzalez JD, Ye YZ, D'Alessandro TL, Estevez AG. Two distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells. Cell Death Differ. 2006;13:1506–1514. [PubMed]
  • Sheng M. The postsynaptic NMDA-receptor--PSD-95 signaling complex in excitatory synapses of the brain. J Cell Sci. 2001;114:1251. [PubMed]
  • Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae. J Cell Biol. 1994;126:353–363. [PMC free article] [PubMed]
  • Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, Huganir RL, Worley PF. Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron. 2006;52:475–484. [PMC free article] [PubMed]
  • Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta -amyloid in hippocampal neurons 10.1073/pnas.95.11.6460. PNAS. 1998;95:6460–6464. [PubMed]
  • Smith TM, Gilliland K, Clawson GA, Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol. 2008;128:1286–1293. [PMC free article] [PubMed]
  • Sprengel R, Suchanek B, Amico C, Brusa R, Burnashev N, Rozov A, Hvalby O, Jensen V, Paulsen O, Andersen P, Kim JJ, Thompson RF, Sun W, Webster LC, Grant SG, Eilers J, Konnerth A, Li J, McNamara JO, Seeburg PH. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell. 1998;92:279–289. [PubMed]
  • Suzuki T, Du F, Tian QB, Zhang J, Endo S. Ca2+/calmodulin-dependent protein kinase IIalpha clusters are associated with stable lipid rafts and their formation traps PSD-95. J Neurochem. 2008;104:596–610. [PubMed]
  • Suzuki T, Ito J, Takagi H, Saitoh F, Nawa H, Shimizu H. Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Brain Res Mol Brain Res. 2001;89:20–28. [PubMed]
  • Swanwick CC, Shapiro ME, Yi Z, Chang K, Wenthold RJ. NMDA receptors interact with flotillin-1 and -2, lipid raft-associated proteins. FEBS Lett. 2009;583:1226–1230. [PubMed]
  • Terpe K. Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol. 2003;60:523–533. [PubMed]
  • Wenthold RJ, Prybylowski K, Standley S, Sans N, Petralia RS. Trafficking of NMDA receptors. Annu Rev Pharmacol Toxicol. 2003;43:335–358. [PubMed]
  • Wheeler D, Knapp E, Bandaru VV, Wang Y, Knorr D, Poirier C, Mattson MP, Geiger JD, Haughey NJ. Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem. 2009;109:1237–1249. [PMC free article] [PubMed]
  • Wong W, Schlichter LC. Differential recruitment of Kv1.4 and Kv4.2 to lipid rafts by PSD-95. J Biol Chem. 2004;279:444–452. [PubMed]
  • Yao WD, Gainetdinov RR, Arbuckle MI, Sotnikova TD, Cyr M, Beaulieu JM, Torres GE, Grant SG, Caron MG. Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron. 2004;41:625–638. [PubMed]
  • Yoshii A, Constantine-Paton M. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat Neurosci. 2007;10:702–711. [PubMed]
  • Zacharias DA, Violin JD, Newton AC, Tsien RY. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science. 2002;296:913–916. [PubMed]
  • Zinebi F, Xie J, Liu J, Russell RT, Gallagher JP, McKernan MG, Shinnick-Gallagher P. NMDA currents and receptor protein are downregulated in the amygdala during maintenance of fear memory. J Neurosci. 2003;23:10283–10291. [PubMed]
  • Zukin RS, Bennett MV. Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci. 1995;18:306–313. [PubMed]